WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens.
WIN 57273 is a new fluoroquinolone with excellent in vitro activity versus gram-positive pathogens, including methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis and gentamicin-susceptible and -resistant Enterococcus faecalis. We compared the microdilution MIC...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphov: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
1990
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175984/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2117417/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.7.1376 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
